Inventor · disambiguated record
Stephen L. Warren
Also filed as: WARREN STEPHEN · WARREN STEPHEN L
5 granted patents·16 pending applications·62 citations·filing 1992–2014
78Inventor score
Top patents by PatentIndex Score
21 records- 0174US8470295B2Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogsWARREN STEPHEN L·Filed 2008·Granted Jun 25, 2013·5 cites·22 claims
- 0267US2008268021A1Adhesive bioerodible ocular drug delivery systemQLT USA INC·Filed 2008·Application pending·0 cites
- 0366US8600479B2Guidance and implantation of cathetersDALKE WILLIAM D·Filed 2008·Granted Dec 3, 2013·7 cites·59 claims
- 0458US2005013845A1Adhesive bioerodible ocular drug delivery systemFiled 2003·Application pending·0 cites
- 0557US2005153994A1The use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skinIOMED INC·Filed 2004·Application pending·0 cites
- 0654US6090784ARNA polymerase II peptides and methods of useUNIV YALE·Filed 1995·Granted Jul 18, 2000·12 cites·26 claims
- 0752US2007142317A1Topical composition for treatment of skin disordersQLT USA INC·Filed 2006·Application pending·0 cites
- 0850US5336615AGenetically engineered endothelial cells exhibiting enhanced migration and plasminogen activator activityUNIV YALE·Filed 1992·Granted Aug 9, 1994·38 cites·19 claims
- 0948US2016030522A1Combination therapy to improve soft tissue healing, fat graft healing, endochondral bone healing and osteointegrationMILLER LEONARD B·Filed 2014·Application pending·0 cites
- 1048US2005153969A1Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicamentIOMED INC·Filed 2004·Application pending·0 cites
- 1146US2008003260A1Use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skinIOMED INC·Filed 2007·Application pending·0 cites
- 1246US2008009501A1Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicamentsIOMED INC·Filed 2007·Application pending·0 cites
- 1344US2009304576A1Device for delivery of anti-cancer agents to tissueWARREN STEPHEN L·Filed 2007·Application pending·0 cites
- 1442US2006121085A1Formulations for cell-schedule dependent anticancer agentsWARREN STEPHEN L·Filed 2005·Application pending·0 cites
- 1542US2011135569A1Method for therapeutic administration of radionucleosidesPEAK BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 1641US2006210604A1Ocular delivery of polymeric delivery formulationsDADEY ERIC·Filed 2005·Application pending·0 cites
- 1737US2007231301A1Parenteral low dose type 1 interferons for bladder cancerWARREN STEPHEN L·Filed 2007·Application pending·0 cites
- 1837US2015044296A1Combination therapy to improve joint, tendon, and ligament healingMILLER LEONARD B·Filed 2013·Application pending·0 cites
- 1936US2010280494A1Catheter and array for anticancer therapyMATSUURA JAMES E·Filed 2007·Application pending·0 cites
- 2035US2009092650A1Sustained Delivery Formulations of Octreotide CompoundsWARREN STEPHEN L·Filed 2005·Application pending·0 cites
- 2126US6007985AMacromolecule delivery method and compositionUNIV YALE·Filed 1994·Granted Dec 28, 1999·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Stephen L. Warren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →